BillionToOne, Inc.

BLLN Healthcare Diagnostics & Research

BillionToOne, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $305.1 million, up 100.0% from fiscal 2024. In the quarter to June 2026, revenue grew 64.4%, EPS grew 817.3%, free cash flow grew 400.7% and total debt rose 74.2%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

98.06 4.67 −4.55%
Market cap
$4.9B
P/E
95.0×
Fwd P/E
99.4×
Dividend yield
—
F-score
n/a
Altman Z
6.04
Beneish M
−2.03
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
ROE

+5 more TTM periods

0.00% 0.00% 0.00% 23.27%
ROA
(10.77%) 0.92% 7.10% 9.09%
ROIC
0.00% 24.01% 38.70% 34.10%
Return on Tangible Assets
(7.68%) 0.55% 4.22% 5.35%
Average Days of Receivables
51.10 49.79 63.11 68.79
Free Cash Flow per Share
(0.39) 0.99 0.57 0.71
Free Cash Flow
(4.04) 15.71 26.40 33.17
Other line items

Show all line items

Columns are period end dates